Overview
Rentokil Initial plc, headquartered in the United Kingdom, is a prominent player in the services sector, primarily focused on pest control, hygiene, and property care. The company operates across numerous countries globally, providing a suite of services that cater to both commercial and residential clients. A notable aspect of Rentokil Initial's business strategy includes its commitment to innovation and sustainability within its industry. One key project in its portfolio is its Integrated Pest Management (IPM) approach, which uses advanced technology and biological research to provide environmentally sensitive pest control solutions. Additionally, the company has a reputation for strategic acquisitions, significantly expanding its market presence and service capabilities. These elements together reflect Rentokil Initial’s dedication to growth, operational excellence, and environmental responsibility.
Basic Stats
The share price of Rentokil Initial plc - Depositary Receipt (Common Stock) as of September 5, 2025 is $25.57 / share. This is an increase of 2.65% from the prior week.
The Factor Analysis chart (below right) shows a view of Rentokil Initial plc - Depositary Receipt (Common Stock) from a variety of lenses. Each factor shows how well the company ranks against all other companies in the Fintel global investing universe. Factor scores range from zero to 100, with 100 being most desirable, and 50 being average.
For example, a company with a Value Score of 100 would be the most undervalued company in our database. A company with a Value Score of zero would be the most overvalued.
| Market Cap | |
| EV | |
| Shares Out. | 2,522.00 MM |
| Earnings Date | |
| EPS (TTM) | 0.10 |
| Dividend Yield | 4.11 % |
| Ex-Dividend Date | 2025-08-15 |
| Borrow Rate | 0.54 |
| Short Shares Avail. | 2.40 MM |
| Short Interest | 3.16 MM |
| Short Float | |
| Days to Cover | 5.90 days |
| Risk Free Rate | 4.22 % |
| Price Change (1 yr) | -18.64 % |
| Volatility (1 yr) | 0.39 |
| Beta | 0.75 |
| Sharpe Ratio (1 yr) | -0.58 |
| Sortino Ratio (1 yr) | -0.79 |
| PE Ratio | |
| Price/Book | |
| Price/TBV | |
| Book/Market | |
| EBIT/EV | |
| EBIT(3yr avg)/EV | |
| ROA | 0.02 |
| ROE | 0.06 |
| ROIC | 0.02 |
| CROIC | 0.02 |
| OCROIC | 0.07 |
| Implied Volatility | 35.33 % |
| Put/Call OI Ratio | 0.20 |
| Growth | |
| Profitability | |
| Quality Score | |
| Value Score | |
| Momentum Score | |
| Stability (Low Vol) Score | |
| Analyst Sentiment | |
| Fund Sentiment | |
| Insider Sentiment | |
| Officer Sentiment | |
| Dividend Score | |
| QVM Score | |
| Piotroski F-SCORE |
Factor Scores range from 0 to 100, with 100 being most desirable. Larger circles are better. In situations where we have no data (e.g. no insider trades), we plot the score at 50 to avoid penalizing companies. However, a company that does not pay dividends will get a Dividend Score of Zero. Additionally, we inverted volatility to create a "stability" metric which is better when higher.
Price Target
The average one-year price target for Rentokil Initial plc - Depositary Receipt (Common Stock) is $28.65. The forecasts range from a low of $21.16 to a high of $38.66. A stock’s price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings. Analysts typically set price targets that correspond to their buy or sell recommendations.
Update Frequency: Monthly
Stock Upgrades/Downgrades
This card shows analyst upgrades/downgrades for Rentokil Initial plc - Depositary Receipt (Common Stock). An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.
The standard analyst ratings are generally as follows:
- Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
- Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
- Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.
When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.
The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.
| Date | Analyst | Prior | Latest Recommendation |
Action |
|---|---|---|---|---|
| 2024-07-02 | JP Morgan Cazenove | Neutral | Reiterate | |
| 2024-06-17 | RBC Capital Markets | Outperform | Reiterate | |
| 2024-04-23 | JP Morgan Cazenove | Buy | Reiterate | |
| 2024-04-18 | Jefferies | Buy | Reiterate | |
| 2024-03-12 | RBC Capital Markets | Outperform | Reiterate | |
| 2024-02-27 | RBC Capital Markets | Outperform | Reiterate | |
| 2023-09-08 | Peel Hunt Limited | Hold | Reiterate | |
| 2023-07-03 | Barclays | Overweight | Reiterate | |
| 2023-07-03 | RBC Capital Markets | Outperform | Reiterate | |
| 2023-05-17 | Jefferies | Buy | Reiterate | |
| 2023-05-17 | HSBC | Hold | Reiterate | |
| 2023-04-21 | Barclays | Overweight | Reiterate | |
| 2023-03-24 | Deutsche | Buy | Reiterate | |
| 2023-03-21 | RBC Capital Markets | Outperform | Reiterate | |
| 2023-03-16 | Numis | Hold | Reiterate | |
| 2023-03-08 | Peel Hunt Limited | Hold | Reiterate | |
| 2023-02-22 | JP Morgan Cazenove | Overweight | Reiterate | |
| 2023-02-07 | Jefferies | Buy | Reiterate | |
| 2023-02-01 | Redburn Partners | Buy | Initiate | |
| 2023-01-05 | RBC Capital Markets | Outperform | Reiterate | |
| 2022-11-14 | Shore Capital | Overweight | Reiterate | |
| 2022-11-03 | Deutsche | Buy | Reiterate | |
| 2022-10-25 | Deutsche | Buy | Reiterate | |
| 2022-10-11 | JP Morgan Cazenove | Overweight | Reiterate | |
| 2022-08-31 | Deutsche | Buy | Reiterate | |
| 2022-08-25 | JP Morgan Cazenove | Overweight | Reiterate | |
| 2022-08-10 | RBC Capital Markets | Outperform | Reiterate | |
| 2022-08-04 | JP Morgan Cazenove | Overweight | Reiterate | |
| 2022-07-13 | Deutsche | Buy | Reiterate | |
| 2022-05-11 | Morgan Stanley | Overweight | Reiterate | |
| 2022-05-04 | Deutsche | Hold | Reiterate | |
| 2022-04-14 | Morgan Stanley | Overweight | Reiterate | |
| 2022-04-07 | JP Morgan Cazenove | Overweight | Reiterate | |
| 2022-04-04 | Citigroup | Buy | Reiterate | |
| 2022-03-09 | Berenberg Bank | Buy | Reiterate | |
| 2022-03-04 | Deutsche | Hold | Reiterate | |
| 2022-02-11 | Peel Hunt Limited | Hold | Reiterate | |
| 2022-02-11 | Peel Hunt Limited | Reiteration | Reiterate | |
| 2022-02-09 | Morgan Stanley | Reiteration | Reiterate | |
| 2022-02-07 | Berenberg Bank | Reiteration | Reiterate | |
| 2022-02-03 | JP Morgan Cazenove | Reiteration | Reiterate | |
| 2022-01-26 | JP Morgan Cazenove | Reiteration | Reiterate | |
| 2022-01-25 | Deutsche | Reiteration | Reiterate | |
| 2022-01-12 | Deutsche | Reiteration | Reiterate | |
| 2021-12-17 | Deutsche | Reiteration | Reiterate | |
| 2021-12-16 | JP Morgan Cazenove | Reiteration | Reiterate | |
| 2021-12-14 | Barclays | Reiteration | Reiterate | |
| 2021-12-14 | Berenberg Bank | Reiteration | Reiterate | |
| 2021-11-15 | Morgan Stanley | Overweight | Reiterate | |
| 2021-10-21 | Barclays | Overweight | Reiterate | |
| 2021-10-19 | Deutsche Bank | Buy | Reiterate | |
| 2021-10-07 | Morgan Stanley | Overweight | Reiterate | |
| 2021-08-04 | Deutsche | Reiteration | Reiterate | |
| 2021-08-04 | Deutsche Bank | Buy | Reiterate | |
| 2021-08-03 | Credit Suisse | Outperform | Reiterate | |
| 2021-08-02 | Berenberg Bank | Sell | Reiterate | |
| 2021-07-30 | Barclays | Overweight | Reiterate | |
| 2021-07-29 | RBC Capital Markets | Outperform | Reiterate | |
| 2021-07-12 | Berenberg Bank | Sell | Reiterate | |
| 2021-03-11 | Berenberg Bank | Sell | Reiterate | |
| 2021-03-05 | Deutsche Bank | Hold | Reiterate | |
| 2021-02-17 | Berenberg Bank | Sell | Reiterate | |
| 2021-02-11 | JP Morgan Cazenove | Overweight | Reiterate | |
| 2021-01-28 | Jefferies | Buy | Reiterate | |
| 2020-11-20 | JP Morgan Cazenove | Overweight | Reiterate | |
| 2020-02-04 | Citigroup | Buy | Reiterate | |
| 2019-10-17 | Peel Hunt LLP | Hold | Reiterate | |
| 2019-09-10 | Deutsche Bank | Hold | Reiterate | |
| 2019-05-07 | JP Morgan Cazenove | Overweight | Reiterate | |
| 2018-07-31 | Numis | Hold | Reiterate | |
| 2018-07-03 | Peel Hunt LLP | Neutral | Reiterate | |
| 2018-06-18 | Credit Suisse | Outperform | Reiterate | |
| 2018-06-12 | RBC Capital Markets | Outperform | Reiterate | |
| 2018-05-17 | Deutsche Bank | Hold | Reiterate | |
| 2018-03-14 | Numis | Add | Reiterate | |
| 2018-03-05 | RBC Capital Markets | Outperform | Reiterate | |
| 2017-12-04 | Jefferies | Hold | Initiate | |
| 2017-08-18 | Deutsche Bank | Buy | Reiterate | |
| 2017-07-28 | JP Morgan Cazenove | Underweight | Reiterate | |
| 2017-07-10 | RBC Capital Markets | Outperform | Reiterate | |
| 2017-04-20 | JP Morgan Cazenove | Underweight | Reiterate | |
| 2017-04-03 | Numis Securities | Add | Initiate | |
| 2017-03-31 | Numis Securities | Add | Reiterate | |
| 2017-02-13 | Deutsche Bank | Buy | Reiterate | |
| 2016-10-24 | Credit Suisse | Outperform | Reiterate | |
| 2016-10-20 | JP Morgan Cazenove | Underweight | Reiterate | |
| 2016-08-09 | Credit Suisse | Outperform | Reiterate | |
| 2016-07-29 | JP Morgan Cazenove | Underweight | Reiterate | |
| 2016-07-29 | Deutsche Bank | Hold | Reiterate | |
| 2016-07-11 | RBC Capital Markets | Top Pick | Reiterate | |
| 2016-07-01 | Credit Suisse | Outperform | Reiterate | |
| 2016-06-06 | Credit Suisse | Outperform | Reiterate | |
| 2016-04-21 | JP Morgan Cazenove | Underweight | Reiterate | |
| 2016-04-05 | RBC Capital Markets | Top Pick | Reiterate | |
| 2016-03-17 | Credit Suisse | Outperform | Reiterate | |
| 2016-02-29 | JP Morgan Cazenove | Underweight | Reiterate | |
| 2016-02-19 | Credit Suisse | Neutral | Reiterate | |
| 2016-02-01 | Deutsche Bank | Hold | Reiterate | |
| 2016-01-25 | Morgan Stanley | Overweight | Reiterate | |
| 2016-01-13 | JP Morgan Cazenove | Underweight | Reiterate | |
| 2015-11-06 | Deutsche Bank | Hold | Reiterate | |
| 2015-11-06 | JP Morgan Cazenove | Overweight | Reiterate | |
| 2015-11-05 | Investec | Buy | Reiterate | |
| 2015-10-28 | RBC Capital Markets | Top Pick | Reiterate | |
| 2015-09-03 | Credit Suisse | Neutral | Reiterate | |
| 2015-08-11 | Credit Suisse | Neutral | Reiterate | |
| 2015-08-07 | JP Morgan Cazenove | Underweight | Reiterate | |
| 2015-07-15 | Credit Suisse | Outperform | Reiterate | |
| 2015-06-05 | Credit Suisse | Outperform | Reiterate | |
| 2015-05-28 | Jefferies | Buy | Reiterate | |
| 2015-05-05 | JP Morgan Cazenove | Underweight | Reiterate | |
| 2015-05-05 | Credit Suisse | Outperform | Reiterate | |
| 2015-04-30 | UBS | Sell | Reiterate | |
| 2015-03-04 | Investec | Buy | Reiterate | |
| 2015-01-09 | Credit Suisse | Outperform | Reiterate | |
| 2014-12-09 | Credit Suisse | Outperform | Reiterate | |
| 2014-11-18 | Jefferies | Hold | Reiterate | |
| 2014-11-10 | JP Morgan Cazenove | Underweight | Reiterate | |
| 2014-11-07 | Investec | Buy | Reiterate | |
| 2014-11-07 | Peel Hunt LLP | Hold | Reiterate | |
| 2014-10-29 | Citigroup | Sell | Reiterate | |
| 2014-10-16 | Credit Suisse | Outperform | Reiterate | |
| 2014-09-23 | Credit Suisse | Outperform | Reiterate | |
| 2014-08-04 | Barclays | Overweight | Reiterate | |
| 2014-08-04 | Jefferies | Hold | Reiterate | |
| 2014-08-01 | Oriel Securities | Hold | Reiterate | |
| 2014-07-30 | Deutsche Bank | Hold | Reiterate | |
| 2014-07-25 | Jefferies | Hold | Reiterate | |
| 2014-07-15 | Jefferies | Hold | Reiterate | |
| 2014-05-06 | Credit Suisse | Neutral | Reiterate | |
| 2014-05-06 | JP Morgan Cazenove | Underweight | Reiterate | |
| 2014-05-02 | Cantor Fitzgerald | Buy | Reiterate | |
| 2014-05-02 | Oriel Securities | Hold | Reiterate | |
| 2014-04-23 | Jefferies | Hold | Reiterate | |
| 2014-03-20 | Citigroup | Sell | Reiterate | |
| 2014-03-12 | Credit Suisse | Neutral | Reiterate | |
| 2014-03-06 | Seymour Pierce | Buy | Reiterate | |
| 2014-03-04 | Barclays | Overweight | Reiterate | |
| 2014-03-03 | Deutsche Bank | Hold | Reiterate | |
| 2014-03-03 | Jefferies | Hold | Reiterate | |
| 2014-02-19 | JP Morgan Cazenove | Underweight | Reiterate | |
| 2014-02-17 | Seymour Pierce | Buy | Reiterate | |
| 2014-01-30 | Jefferies | Hold | Reiterate | |
| 2013-12-17 | Credit Suisse | Neutral | Reiterate | |
| 2013-12-10 | Barclays | Overweight | Reiterate | |
| 2013-12-02 | Barclays | Overweight | Reiterate | |
| 2013-11-12 | Jefferies | Hold | Reiterate | |
| 2013-11-11 | JP Morgan Cazenove | Underweight | Reiterate | |
| 2013-11-08 | Deutsche Bank | Hold | Reiterate | |
| 2013-11-05 | Panmure Gordon | Hold | Reiterate | |
| 2013-09-16 | Citigroup | Sell | Reiterate | |
| 2013-08-14 | Investec | Hold | Reiterate | |
| 2013-08-07 | Panmure Gordon | Hold | Reiterate | |
| 2013-07-04 | HSBC | Underweight | Reiterate | |
| 2025-01-14 | JP Morgan Cazenove | Neutral | Reiterate | |
| 2024-07-31 | RBC Capital Markets | Outperform | Reiterate | |
| 2024-09-12 | Deutsche | Buy | Reiterate | |
| 2025-03-07 | Deutsche | Buy | Reiterate | |
| 2025-08-01 | RBC Capital Markets | Outperform | Reiterate | |
| 2025-08-11 | JP Morgan Cazenove | No Recommendation | Reiterate | |
| 2025-07-21 | Deutsche | Buy | Reiterate |
